Upcoming Courses

28th Summer Seminars: Clinical Psychopharmacology: A Master Class

Ross Baldessarini, MD, Dsc (hon.)

July 7, 2017 – July 9, 2017 | Edgartown, MA | Harbor View Hotel More Information

This seminar will address recent clinical research that forms the basis of rational, evidence-based clinical practice in the care of patients with bipolar disorder, major depression, schizophrenia, other psychotic disorders, and severe anxiety disorders. It will emphasize and critically address the evidence base that guides clinical practice in the use of psychotropic medicines to these disorders, considering short-term and long term
efficacy and dosing of antipsychotic, mood-stabilizing, antidepressant drugs, and anti-anxiety agents as well as their adverse-effect risks. Participants are expected to be experienced clinicians (psychiatrists, other physicians, nurse practitioners, psychologists, social workers) with curiosity about the procedures and findings of modern clinical and experimental therapeutics research as a sound basis for improved clinical practice. Educational presentation will be in seminar format and include lectures, participant discussion and Q&A.

This course is designed so that participants will be able to:

Describe and critically evaluate the evolution of clinical psychopharmacology over the past
half-century, its current status, and future prospects;
• Describe and critically evaluate evidence supporting short- and long-term treatment
of patients with psychotic disorders;
• Describe and critically evaluate evidence supporting short- and long-term treatment
of patients with bipolar disorders;
• Describe and critically evaluate evidence supporting short- and long-term treatment
of patients with major depressive disorder;
• Describe and critically evaluate evidence supporting short- and long-term treatment
of patients with severe anxiety disorders;
• Assess potentially severe adverse effects of psychotropic drug treatment;
• Improve skills in avoiding, limiting and managing risk of adverse effects
of psychotropic drug treatment;
• Evaluate treatment practices involving psychotropic drugs and develop strategies
to improve clinical practice;
• Analyze current relationships between treatment with psychotropic drugs and risk of mortality
due to suicide and other aspects of increased mortality risks in psychiatric patients;
• Better integrate psychopharmacology into the comprehensive care of patients;
• Critically assess advantages and limitations of clinical psychopharmacology;
• Critically assess the impact of clinical psychopharmacology on theory, training, research,
and practice of contemporary clinical psychiatry.

Additional Information

Friday: Registration – 4:00 PM; Seminar: 4:30-6:30PM

Saturday and Sunday: 8:15 – 12:30 PM

Beth Israel Deaconess Department of Psychiatry Foundation, Inc./Contact Hours: 10